Ibrexafungerp

Ibrexafungerp is a first-in-class, orally active triterpenoid antifungal agent. It is structurally distinct from azoles and echinocandins and was developed specifically to overcome resistance and tolerability issues seen with older antifungals. Its therapeutic use is listed as anti-infectives and antifungals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include ibrexafungerpum, pyridin-4-yl-1, 2, 4-triazol-1-yl)-17-oxapentacyclo(13.3.3.01, 14.02, 11.05 and 10)henicos-2-ene-6-carboxylic acid. Its PubChem CID is 46871657.

CAS No 1207753-03-4
Molecular Formula C44H67N5O4
Molecular Weight 730.0 g/mol
Synonyms (1R,5S,6R,7R,10R,11R,14R,15S,20R,21R)-21-[(2R)-2-amino-2,3,3-trimethylbutoxy]-5,7,10,15-tetramethyl-7-[(2R)-3-methylbutan-2-yl]-20-(5-pyridin-4-yl-1,2,4-triazol-1-yl)-17-oxapentacyclo[13.3.3.01,14.02,11.05,10]henicos-2-ene-6-carboxylic acid

Frequently Asked Questions